47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -37,1 | |||
Gross profit (loss) | -0,1 | -0,1 | -0,1 | 7,2 |
EBITDA | -65,7 | |||
Short time liabilities | 33,4 | |||
Income tax | 0 | 0 | -0 | ∞ |
Other operating costs | 1568,6 | |||
Equity capital | -1,1 | -1,2 | -1,4 | -11,1 |
Operating profit (EBIT) | -66,6 | |||
Assets | 0,3 | 0,4 | 0,5 | 7,8 |
Net profit (loss) | -0,1 | -0,1 | -0,1 | 8,5 |
Cash | -36 | |||
Liabilities and provisions for liabilities | 1,4 | 1,7 | 1,8 | 10,3 |
Net income from sale | 44,8 | |||
Working assets | 0,3 | 0,4 | 0,4 | 10,8 |
Other income costs | 58 615,4 | |||
Basic operational activity income | 1,6 | 2,1 | 2,3 | 9,6 |
Depreciation | 82 | |||
% | % | % | p.p. | |
Profitability of capital | -39,2 | |||
Equity capital to total assets | -363,5 | -291,6 | -300,6 | -9 |
Gross profit margin | -8,9 | -7,2 | -6,1 | 1,1 |
EBITDA Margin | -3,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -31 | |||
Current financial liquidity indicator | -0,2 | |||
Net dept to EBITDA | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane